Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medmen Enterprises Inc MMNFQ

MedMen Enterprises Inc. is a retail cannabis company with an operational footprint in California, Nevada, Illinois, Massachusetts, and New York. The Company offers a robust selection of high-quality products, including MedMen-owned brands MedMen Red, Moss and LuxLyte, through its premium retail stores, proprietary delivery service, as well as curbside and instore pickup. MedMen Buds, a loyalty program, provides access to promotions, product drops and content. It produces and curates the consumer product assortment for retail operations in its local communities with services and engaging in-store experience, combined with reward, delivery, and e-commerce programs. It also offers buds rewards, where buds members earn points with every purchase, plus exclusive access to drops and deals. The Company also provides gift cards.


GREY:MMNFQ - Post by User

Bullboard Posts
Comment by meowmeowmeowon Mar 13, 2019 4:35pm
85 Views
Post# 29481490

RE:Its time for a change.

RE:Its time for a change. Very well written, thanks.
As someone who is shifting their money away from Canadian LP's - mainly Aphria, would you recommend now as  good entry point for MedMen? It's close to 52WL and the marketcap is reasonable now. 

DonkeyZub wrote: My letter to management:
I suggest you all write the same type of letter. It’s time for a change. 

I not inclined to write to companies I’m shareholder of as I hate to invest in a company that I have to provide my two cents of advice to. 
 
You need to consider selling the company. I’m a long time investor in the sector and my holdings are diverse. I participated in Medmen’s IPO and have accumulated a position of 300,000 shares between my personal and corporate accounts. 
 
The sector as a whole has rallied drastically between December 24 to present day. Medmen has sunken rather disappointingly. The missteps of PPs and the obscure share structure, lawsuits and accusations of misappropriation of funds by the founders is becoming too much of an elephant to ignore. 
 
I highly recommend either a outright sale of the company to one your competitors or a shift in leadership...ASAP. Curaleaf is an excellent suitor. As a long term shareholder of Curaleaf I’m very knowledgeable of their very healthy war chest of cash and their managements hunger to grow with an excellent track record of managing a publicly traded company. 
 
One way or the other, the boys need to go. They did a great job of bringing the company to this point. They need to now employ smart people to take it to the next level. You will have no participants in the next capital raise which you will need in 8 months. 
 
My two cents. Thank you. 
 


Bullboard Posts